KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $42,000 | -78.2% | 12,660 | -75.2% | 0.00% | – |
| Q2 2018 | $193,000 | -80.5% | 51,071 | -78.9% | 0.00% | – |
| Q1 2018 | $990,000 | +254.8% | 242,200 | +302.3% | 0.00% | – |
| Q4 2017 | $279,000 | +11.2% | 60,200 | +70.1% | 0.00% | – |
| Q3 2017 | $251,000 | -50.7% | 35,382 | -49.8% | 0.00% | – |
| Q2 2017 | $509,000 | +17.3% | 70,467 | 0.0% | 0.00% | – |
| Q1 2017 | $434,000 | +1636.0% | 70,467 | +1254.4% | 0.00% | – |
| Q1 2016 | $25,000 | -13.8% | 5,203 | -5.8% | 0.00% | – |
| Q4 2015 | $29,000 | -78.2% | 5,522 | -85.3% | 0.00% | – |
| Q3 2015 | $133,000 | +6550.0% | 37,558 | +18679.0% | 0.00% | – |
| Q2 2015 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | -91.9% | 200 | -91.8% | 0.00% | – |
| Q2 2014 | $37,000 | +1133.3% | 2,430 | +1115.0% | 0.00% | – |
| Q1 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | 0.0% | 200 | -20.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |